WASHINGTON - For months, Reta Mays' treachery slipped through the cracks at the VA hospital center in West Virginia, where ...

Insulet's impressive growth with its Omnipod system, robust 2024 results, and surging valuation make it attractive. See more ...

The Helmsley Charitable Trust’s T1D Exercise Initiative ( T1-DEXI) datasets provide baseline information on the glycemic ...

Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps. The company produces and sells Omnipod, an automated insulin ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin.

Mariposa California's original daily updated online newspaper is the premier site for news and information on Yosemite, ...